S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
Log in
ASX:PAA

PharmAust Competitors

Add
Compare
Today's Range N/A
50-Day Range
A$0.11
MA: A$0.11
A$0.11
52-Week Range N/A
Volume3.27 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

PharmAust (ASX:PAA) Vs. CHV, DDXS, PREV, TNGN, COM, and MYM

Should you be buying PAA stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to PharmAust, including (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), and 17031 (MYM).

PharmAust (ASX:PAA) and (CHV) (CNSX:CHV) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, earnings, dividends and institutional ownership.

Valuation and Earnings

This table compares PharmAust and (CHV)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PharmAust$4.12 million0.00$-1,583,649.92A($0.01)N/A
(CHV)N/AN/AN/AN/AN/A

(CHV) has lower revenue, but higher earnings than PharmAust.

Profitability

This table compares PharmAust and (CHV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PharmAustN/AN/AN/A
(CHV)N/AN/AN/A

Analyst Recommendations

This is a summary of current ratings for PharmAust and (CHV), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
PharmAust0000N/A
(CHV)0000N/A

Summary

PharmAust beats (CHV) on 1 of the 1 factors compared between the two stocks.

PharmAust (ASX:PAA) and (DDXS) (OTCMKTS:DDXS) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability.

Analyst Ratings

This is a summary of recent recommendations for PharmAust and (DDXS), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
PharmAust0000N/A
(DDXS)0000N/A

Earnings & Valuation

This table compares PharmAust and (DDXS)'s revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PharmAust$4.12 million0.00$-1,583,649.92A($0.01)N/A
(DDXS)N/AN/AN/AN/AN/A

(DDXS) has lower revenue, but higher earnings than PharmAust.

Profitability

This table compares PharmAust and (DDXS)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PharmAustN/AN/AN/A
(DDXS)N/AN/AN/A

Summary

PharmAust beats (DDXS) on 1 of the 1 factors compared between the two stocks.

PharmAust (ASX:PAA) and (PREV) (CNSX:PREV) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, valuation, institutional ownership, profitability, earnings and dividends.

Profitability

This table compares PharmAust and (PREV)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PharmAustN/AN/AN/A
(PREV)N/AN/AN/A

Valuation & Earnings

This table compares PharmAust and (PREV)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PharmAust$4.12 million0.00$-1,583,649.92A($0.01)N/A
(PREV)N/AN/AN/AN/AN/A

(PREV) has lower revenue, but higher earnings than PharmAust.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for PharmAust and (PREV), as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
PharmAust0000N/A
(PREV)0000N/A

Summary

PharmAust beats (PREV) on 1 of the 1 factors compared between the two stocks.

PharmAust (ASX:PAA) and (TNGN) (OTCMKTS:TNGN) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, valuation, institutional ownership, risk and dividends.

Analyst Ratings

This is a summary of current recommendations and price targets for PharmAust and (TNGN), as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
PharmAust0000N/A
(TNGN)0000N/A

Valuation & Earnings

This table compares PharmAust and (TNGN)'s gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PharmAust$4.12 million0.00$-1,583,649.92A($0.01)N/A
(TNGN)N/AN/AN/AN/AN/A

(TNGN) has lower revenue, but higher earnings than PharmAust.

Profitability

This table compares PharmAust and (TNGN)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PharmAustN/AN/AN/A
(TNGN)N/AN/AN/A

Summary

PharmAust beats (TNGN) on 1 of the 1 factors compared between the two stocks.

138267 (COM.TO) (TSE:COM) and PharmAust (ASX:PAA) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and valuation.

Profitability

This table compares 138267 (COM.TO) and PharmAust's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
138267 (COM.TO)N/AN/AN/A
PharmAustN/AN/AN/A

Analyst Recommendations

This is a breakdown of current ratings for 138267 (COM.TO) and PharmAust, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
138267 (COM.TO)0000N/A
PharmAust0000N/A

Earnings and Valuation

This table compares 138267 (COM.TO) and PharmAust's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
138267 (COM.TO)N/AN/AN/AN/AN/A
PharmAust$4.12 million0.00$-1,583,649.92A($0.01)N/A

138267 (COM.TO) has higher earnings, but lower revenue than PharmAust.

Summary

PharmAust beats 138267 (COM.TO) on 1 of the 1 factors compared between the two stocks.

PharmAust (ASX:PAA) and 17031 (CNSX:MYM) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends.

Profitability

This table compares PharmAust and 17031's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
PharmAustN/AN/AN/A
17031N/AN/AN/A

Valuation & Earnings

This table compares PharmAust and 17031's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PharmAust$4.12 million0.00C$-1,583,649.92A($0.01)N/A
17031N/AN/AN/AN/AN/A

17031 has lower revenue, but higher earnings than PharmAust.

Analyst Recommendations

This is a summary of current ratings and recommmendations for PharmAust and 17031, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
PharmAust0000N/A
170310000N/A

Summary

PharmAust beats 17031 on 1 of the 1 factors compared between the two stocks.


PharmAust Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
CHV
(CHV)
0.5N/AN/A$0.00N/A0.00High Trading Volume
(DDXS) logo
DDXS
(DDXS)
0.5$0.00flat$0.00N/A0.00
PREV
(PREV)
0.7N/AN/A$0.00N/A0.00High Trading Volume
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Up
COM
138267 (COM.TO)
0.5N/AN/AC$0.00N/A0.00
MYM
17031
0.4N/AN/AC$0.00N/A0.00
4BB
4basebio UK Societas
0.3N/AN/A£0.00N/A0.00Upcoming Earnings
Insider Buying
News Coverage
Gap Down
ATTBF
Abattis Bioceuticals
0.4$0.02flat$0.00N/A0.00Gap Up
Abzena plc (ABZA.L) logo
ABZA
Abzena plc (ABZA.L)
0.6$15.75flat£0.00N/A0.00
ACR
Acrux
0.9N/AN/A$0.00$1.25 million0.00High Trading Volume
News Coverage
Gap Up
ACW
Actinogen Medical
0.5N/AN/A$0.00$3.52 million0.00High Trading Volume
Gap Up
1AD
AdAlta
0.8N/AN/A$0.00$3.83 million0.00High Trading Volume
News Coverage
Gap Up
ADTX
ADiTx Therapeutics
1.0$3.03flat$0.00N/A0.00Gap Up
AHZ
Admedus
0.5N/AN/A$0.00N/A0.00High Trading Volume
AGNPF
Algernon Pharmaceuticals
0.0$0.28flat$0.00N/A0.00Gap Down
LBTSF
Almirall
0.5$12.40flat$0.00N/A0.00
AMBS
Amarantus BioScience
0.5N/AN/A$0.00N/A0.00High Trading Volume
ATX
Amplia Therapeutics
0.8N/AN/A$0.00$894,155.000.00High Trading Volume
Gap Up
ANR
Anatara Lifesciences
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
ANVS
Annovis Bio
0.0N/AN/A$0.00N/A0.00High Trading Volume
CBDC
Apotheca Biosciences
0.4$0.03flat$0.00N/A0.00High Trading Volume
Gap Up
ARNI
Arno Therapeutics
0.5$0.00flat$0.00N/A0.00Gap Up
ASCLF
Ascletis Pharma
0.4$0.37flat$0.00N/A0.00
CDMOP
Avid Bioservices
0.3$29.60flat$0.00N/A0.00Gap Down
AXIM
AXIM Biotechnologies
0.4$0.65flat$0.00N/A0.00
BXRXV
Baudax Bio
0.5N/AN/A$0.00N/A0.00High Trading Volume
BRRGF
BerGenBio ASA
0.7$3.88flat$0.00N/A0.00
BGT
Bio-Gene Technology
0.5N/AN/A$0.00$82,795.000.00High Trading Volume
Gap Up
BNO
Bionomics Limited (BNO.AX)
0.5N/AN/A$0.00$3.19 million0.00High Trading Volume
Gap Up
BIT
Biotron
0.5N/AN/A$0.00$853,026.000.00High Trading Volume
Gap Up
BXN
Bioxyne
0.5N/AN/A$0.00$2.32 million0.00High Trading Volume
Gap Up
BOT
Botanix Pharmaceuticals
0.5N/AN/A$0.00$7.56 million0.00High Trading Volume
Gap Up
BPH
BPH Energy
0.5N/AN/A$0.00$240,243.000.00High Trading Volume
Gap Up
BTC
BTC Health Limited (BTC.AX)
0.5N/AN/A$0.00$131,934.000.00High Trading Volume
News Coverage
Gap Up
CNBX
Cannabics Pharmaceuticals
0.4$0.43flat$0.00N/A0.00News Coverage
Gap Up
ORHOF
CannaRoyalty
0.7$9.23flat$0.00N/A0.00Gap Down
CDXI
Cardax
0.0N/AN/A$0.00N/A0.00High Trading Volume
CDY
Cellmid Limited (CDY.AX)
0.8N/AN/A$0.00$7.48 million0.00High Trading Volume
Gap Up
CBBT
Cerebain Biotech
0.0$0.14flat$0.00N/A0.00Gap Up
CGYG
China Longyi Group International
0.4$0.00flat$0.00N/A0.00
CLVLY
Clinuvel Pharmaceuticals
1.0$16.95flat$0.00N/A0.00
CUV
Clinuvel Pharmaceuticals
0.6N/AN/A$0.00$32.57 million0.00High Trading Volume
Gap Up
CELZ
Creative Medical Technology
0.5$0.05flat$0.00N/A0.00Gap Up
CSL Limited (CSL.AX) logo
CSL
CSL Limited (CSL.AX)
0.8N/AN/A$0.00$9.98 billion0.00Dividend Cut
High Trading Volume
Gap Up
CLXPF
Cybin
1.0$1.27flat$0.00N/A0.00
CYP
Cynata Therapeutics
0.9N/AN/A$0.00$7.01 million0.00High Trading Volume
Gap Up
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
ETBI
Eastgate Biotech
0.5$0.00flat$0.00N/A0.00
EMMBF
Emblem
0.6$1.40flat$0.00N/A0.00
ENZC
Enzolytics
0.0$0.60flat$0.00N/A0.00Gap Up
This page was last updated on 2/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.